Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

Antiviral treatments targeting the coronavirus disease 2019 are urgently required. We screened a panel of already approved drugs in a cell culture model of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and identified two new agents having higher antiviral potentials than the drug cand...

Full description

Bibliographic Details
Main Authors:	Ohashi, H, Watashi, K, Saso, W, Shionoya, K, Iwanami, S, Hirokawa, T, Shirai, T, Kanaya, S, Ito, Y, Kim, KS, Nomura, T, Suzuki, T, Nishioka, K, Ando, S, Ejima, K, Koizumi, Y, Tanaka, T, Aoki, S, Kuramochi, K, Hashiguchi, T, Maenaka, K, Matano, T, Muramatsu, M, Saijo, M, Aihara, K, Iwami, S, Takeda, M, McKeating, JA, Wakita, T
Format:	Journal article
Language:	English
Published:	Cell Press 2021

Similar Items

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
by: Hirofumi Ohashi, et al.
Published: (2021-04-01)

Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
by: Kaho Shionoya, et al.
Published: (2021-04-01)

A multicenter randomized controlled trial to evaluate the efficacy and safety of nelfinavir in patients with mild COVID-19
by: Miyazaki, T, et al.
Published: (2023)

Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
by: Atsushi Hijikata, et al.
Published: (2022-01-01)

Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: a modeling study
by: Iwanami, S, et al.
Published: (2021)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
by: Kim, KS, et al.
Published: (2021)

Simulation of pharmacokinetic drug-drug interaction and dosage regimens optimization of nelfinavir and cepharanthine as a potential combination against COVID-19
by: Wichit Nosoongnoen
Published: (2023-01-01)

Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma.
by: Shoya Iwanami, et al.
Published: (2020-07-01)

Pharmacological Activity of Cepharanthine
by: Ke Liu, et al.
Published: (2023-06-01)

A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19
by: Taiga Miyazaki, et al.
Published: (2023-06-01)

Pharmacological Effects and Clinical Prospects of Cepharanthine
by: Di Liang, et al.
Published: (2022-12-01)

Revisiting the guidelines for ending isolation for COVID-19 patients
by: Yong Dam Jeong, et al.
Published: (2021-07-01)

Inhibition of porcine deltacoronavirus entry and replication by Cepharanthine
by: Yumei Sun, et al.
Published: (2024-02-01)

Induction of Suicidal Erythrocyte Death by Nelfinavir
by: Rosi Bissinger, et al.
Published: (2015-05-01)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
by: Lenka Besse, et al.
Published: (2023-03-01)

Elevated ethyl methanesulfonate (EMS) in nelfinavir mesylate (Viracept<sup>®</sup>, Roche): overview
by: Jones Judith K, et al.
Published: (2009-08-01)

The genome of Stephania japonica provides insights into the biosynthesis of cepharanthine
by: Zhuo Liu, et al.
Published: (2024-03-01)

Nelfinavir: An Old Ally in the COVID-19 Fight?
by: Anna Gidari, et al.
Published: (2022-12-01)

Estimation of the incubation period of COVID-19 using viral load data
by: Keisuke Ejima, et al.
Published: (2021-06-01)

Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury
by: Di Liang, et al.
Published: (2023-05-01)

A mechanistic updated overview on Cepharanthine as potential anticancer agent
by: YingZheng Wang, et al.
Published: (2023-09-01)

Cepharanthine and Curcumin inhibited mitochondrial apoptosis induced by PCV2
by: Yinlan Xu, et al.
Published: (2020-09-01)

The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir
by: Mahbuba R. Subeha, et al.
Published: (2020-11-01)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
by: Anjali K. Gupta, et al.
Published: (2007-04-01)

GPS observations of medium-scale traveling ionospheric disturbances over Europe
by: Y. Otsuka, et al.
Published: (2013-02-01)

Clinical trial of oral nelfinavir before and during radiation therapy for advanced rectal cancer
by: Hill, E, et al.
Published: (2016)

Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro
by: Hirofumi Ohashi, et al.
Published: (2021-03-01)

Cepharanthine loaded nanoparticles coated with macrophage membranes for lung inflammation therapy
by: Caihong Lu, et al.
Published: (2021-01-01)

Cepharanthine and Oral Lichen Planus Efficacy (COLE) study: protocol for a multicentre randomised controlled study assessing the efficacy and safety of cepharanthine with topical corticosteroids in oral lichen planus
by: Kazuhiko Yamamoto, et al.
Published: (2023-08-01)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
by: Holyoake, D, et al.
Published: (2016)

New insights into the in silico prediction of HIV protease resistance to nelfinavir.
by: Dinler A Antunes, et al.
Published: (2014-01-01)

Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data: mathematical modelling study
by: Keisuke Ejima, et al.
Published: (2022-07-01)

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
by: Léon Juan, et al.
Published: (2006-07-01)

Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery
by: Liang Leng, et al.
Published: (2024-02-01)

Cepharanthine Induces Autophagy, Apoptosis and Cell Cycle Arrest in Breast Cancer Cells
by: Sumei Gao, et al.
Published: (2017-03-01)

In vitro inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes
by: Xunge Zhang, et al.
Published: (2020-01-01)

Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption
by: Chen-he Zhou, et al.
Published: (2018-03-01)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
by: Kwang Su Kim, et al.
Published: (2021-03-01)

The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells
by: Al-Assar, O, et al.
Published: (2016)

The efficacy of nelfinavir and lopinavir/ritonavir in the treatment of HIV-infected pediatric patients
by: V. B. Denisenko,, et al.
Published: (2018-12-01)